PNC Financial Services Group
NAVB

PNC Financial Services Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

PNC Financial Services Group’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-750
Closed -$2K – 4221
2018
Q4 		$2K Hold
750
– – ﹤0.01% 3914
2018
Q3 		$3K Hold
750
– – ﹤0.01% 3925
2018
Q2 		$3K Hold
750
– – ﹤0.01% 3958
2018
Q1 		$5K Buy
+750
New +$5.61K ﹤0.01% 3904
2015
Q1 		– Sell
-50
Closed -$2K – 4803
2014
Q4 		$2K Buy
+50
New +$1.38K ﹤0.01% 3865

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group's NAVB Position: Q1 2019 in Review

PNC Financial Services Group sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2019, closing a stake of 750 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in NAVB in Q4 2014 and held it in 5 quarters. The position peaked at $5K in Q1 2018. 49 funds tracked by Wall St. Rank hold NAVB as of Q1 2019.

  • PNC Financial Services Group reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 750 Navidea Biopharmaceuticals Inc. shares in Q1 2019, an estimated $2K.
  • PNC Financial Services Group first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2014 and held it in 5 quarters.
  • PNC Financial Services Group's Navidea Biopharmaceuticals Inc. position peaked at $5K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2019.

Based on PNC Financial Services Group's 13F filing for Q1 2019, filed 10 May 2019.